These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3969068)

  • 1. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB; Guan JH; Neumeyer JL; Seeman P
    Mol Pharmacol; 1985 Feb; 27(2):193-9. PubMed ID: 3969068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptors photolabeled by iodo-azido-clebopride.
    Niznik HB; Dumbrille-Ross A; Guan JH; Neumeyer JL; Seeman P
    Neurosci Lett; 1985 Apr; 55(3):267-72. PubMed ID: 3159976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-photoaffinity labeling of the D2-dopamine receptor.
    Kanety H; Fuchs S
    Biochem Biophys Res Commun; 1988 Sep; 155(2):930-6. PubMed ID: 2458727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of dopamine D2 receptors by sodium and pH.
    Neve KA
    Mol Pharmacol; 1991 Apr; 39(4):570-8. PubMed ID: 2017157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dopamine D2 receptor photolabel: azidoclebopride.
    Niznik HB; Guan JH; Neumeyer JL; Seeman P
    Eur J Pharmacol; 1984 Sep; 104(3-4):389-90. PubMed ID: 6499931
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.
    Jarvie KR; Niznik HB; Seeman P
    Mol Pharmacol; 1988 Aug; 34(2):91-7. PubMed ID: 2970586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
    Kilpatrick GJ; el Tayar N; Van de Waterbeemd H; Jenner P; Testa B; Marsden CD
    Mol Pharmacol; 1986 Sep; 30(3):226-34. PubMed ID: 2943980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone.
    Niznik HB; Grigoriadis DE; Seeman P
    FEBS Lett; 1986 Dec; 209(1):71-6. PubMed ID: 2948835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
    Schonwetter BS; Luedtke RR; Kung MP; Billings J; Kung HF; Molinoff PB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):110-6. PubMed ID: 2526213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoaffinity labeling of the D2-dopamine receptor using a novel high affinity radioiodinated probe.
    Amlaiky N; Caron MG
    J Biol Chem; 1985 Feb; 260(4):1983-6. PubMed ID: 2579064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
    Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoaffinity labelling of dopamine receptors. Synthesis and binding characteristics of azapride.
    Wouters W; Van Dun J; Laduron PM
    Eur J Biochem; 1984 Dec; 145(2):273-8. PubMed ID: 6548707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [125I]-N-(p-aminophenethyl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of the rat pituitary gland: a thermodynamic study.
    Agui T; Amlaiky N; Caron MG; Kebabian JW
    Mol Pharmacol; 1988 Feb; 33(2):163-9. PubMed ID: 2963208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
    David C; Fuchs S
    Mol Pharmacol; 1991 Nov; 40(5):712-6. PubMed ID: 1834930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
    J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.